Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.66
Delayed Data
As of Sep 23
 0.00 / 0.00%
Today’s Change
0.67
Today|||52-Week Range
1.90
+37.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues22.6M20.6M26.5M45.7M
 
 
 
 
 
Cost of Goods Sold9.3M8.8M10.4M18.4M
 
 
 
 
 
Depreciation And Amortization231.0K493.3K1.2M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income13.1M11.4M14.9M25.7M
 
 
 
 
 
General Expenses24.5M32.1M48.3M46.1M
 
 
 
 
 
Research And Development14.9M15.3M18.6M19.7M
 
 
 
 
 
Total Operating Expenses34.0M41.4M59.9M66.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.5M-20.8M-33.4M-20.4M
 
 
 
 
 
Extraordinary Charge0.00-65.0K-1.7M-31.5K
 
 
 
 
Other Expenses-39.1K-68.0K-90.1K-82.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.4M-20.8M-35.1M-20.5M
 
 
 
 
 
Income Taxes0.00-300.0K-25.0K-175.0K
 
 
 
 
Net Income-11.4M-20.5M-35.2M-20.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS110.2M126.9M130.5M146.6M
 
 
 
 
 
Shares To Calculate EPS Diluted110.2M126.9M130.5M146.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.16-$0.27-$0.14
 
 
 
 
 
EPS Diluted-$0.10-$0.16-$0.27-$0.14